Key result
Preliminary data suggest that maternal antithrombotic prophylaxis may improve gestational outcomes in women with thrombophilia, with randomized trials currently underway.
Why the study?
Does maternal antithrombotic prophylaxis improve gestational outcomes in pregnant women with thrombophilia?
Does maternal antithrombotic prophylaxis improve gestational outcomes in pregnant women with thrombophilia?
Preliminary evidence suggests antithrombotic prophylaxis may improve gestational outcomes in women with thrombophilia, pending results from ongoing randomized trials.
No takes yet. Share an insight, caveat, or question.
Should not alter practice yet; leaves open possible benefit pending ongoing randomized trials.
Benjamin Brenner (2004) conducted a review in Thrombophilia-related placental vascular complications. Maternal antithrombotic prophylaxis was evaluated. Preliminary data suggest that maternal antithrombotic prophylaxis may improve gestational outcomes in women with thrombophilia, with randomized trials currently underway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: